The story of Sildenafil offers a complicated case study for investors eyeing pharma. While first sales were astounding, recent patent lapse and the rise of cheaper versions have severely impacted profitability. In https://honeyfdqd853397.blogtov.com/21721735/viagra-and-the-pharmaceutical-industry-a-precarious-stake